Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Frontiers in Chemistry|June 10, 2021
Chemical Composition, Antimicrobial and Insecticidal Activities of Essential Oils of Discarded Perfume Lemon and Leaves (<i>Citrus Limon</i> (L.) Burm. F.) as Possible Sources of Functional Botanical AgentsPanpan Wu, Xiaowen Tang, Rongchao Jian, et al.
Oncotarget|January 28, 2016
A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathwayZubin Zhang, Hongwu Mao, Xiaolin Du, et al.
Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.
Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.
Frontiers in Immunology|December 16, 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phaseQingya Cui, Peiqi Liang, Haiping Dai, et al.
Annals of Hematology|June 20, 2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantationXuanqi Cao, Zheng Li, Yanming Zhang, et al.
Hematological Oncology|October 4, 2021
TNF-α increases the risk of bleeding in patients after CAR T-cell therapy: A bleeding model based on a real-world study of Chinese CAR T Working PartyJiaqian Qi, Xin Lv, Jia Chen, et al.
Frontiers in Immunology|April 4, 2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T TherapyJingxian Gu, Sining Liu, Wei Cui, et al.
Bioorganic Chemistry|February 24, 2021
Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agentsPanpan Wu, Borong Tu, Jinfeng Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2025
Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III TrialXiang Zhang, Yue Han, Huiying Qiu, et al.
Pageof 22